SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-335927
Filing Date
2017-11-07
Accepted
2017-11-07 17:23:03
Documents
4
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d271657d8k.htm 8-K 17514
2 EX-99.1 d271657dex991.htm EX-99.1 74719
3 EX-99.2 d271657dex992.htm EX-99.2 38431
4 GRAPHIC g271657g1102154503700.jpg GRAPHIC 3237
  Complete submission text file 0001193125-17-335927.txt   136513
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10352 | Film No.: 171184446
SIC: 2834 Pharmaceutical Preparations